BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections

Expands BD GeneOhm(TM) Assay Menu to Detect Major Healthcare-Associated Infections (HAIs) SAN DIEGO, Jan. 12 -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX) , announced today it has received clearance from the U.S. Food and Drug Administration to market the BD GeneOhm(TM) Cdiff molecular assay for the rapid detection of [...]

Waters Corporation Updates Business Conditions

MILFORD, Mass.--Jan. 12, 2009--Waters Corporation (NYSE: WAT) announced today that fourth quarter 2008 preliminary sales are approximately $418 million. On December 11, 2008, the Company revised its fourth quarter 2008 sales and earnings outlook due to anticipated reduced sales volume resulting from weaker global economic conditions, constrained capital spending and unfavorable foreign currency translation impacts. [...]

Illumina Genome Analyzer Selected by Internationally Recognized Medical Center to Sequence 50 Human Genomes

Illumina (NASDAQ:ILMN) today announced that researchers at Duke University Medical Center will utilize Illumina’s Genome Analyzer to study the resistance to HIV infection among 50 individuals that were highly exposed to the virus, but who remain uninfected. Duke University researchers will sequence the complete genome of at least 50 individuals with the desired phenotype. David [...]

Danaher Announces Executive Appointments

WASHINGTON, Jan. 12 -- Danaher Corporation (NYSE: DHR - News) announced today that David Martyr, Jonathan Clark, Kevin Layne, Richard McBee and Gregory Beason have each been appointed Vice President and Group Executive of Danaher. H. Lawrence Culp, Jr., President and Chief Executive Officer of Danaher, stated, "I am pleased to be able to make [...]

Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement

Milestone Achieved A Year Ahead of Schedule ST. LOUIS and RICHMOND, Calif., Jan. 12 -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced it has reached a major production capacity milestone as part of its agreement with Sigma-Aldrich Corporation (Nasdaq: SIAL) to commercialize zinc finger nuclease reagents (ZFNs) for research applications. The milestone triggers a payment [...]

Micromeritics’ GeoPyc 1360 Envelope Density Analyzer, an Important Analytical Tool for Pharmaceutical Roller Compaction Applications

Micromeritics’ GeoPyc 1360 Density Analyzer is an ideal tool for the determination of the bulk density of roller compactions and the ribbon created during the process Norcross, GA - 1/12/2009 -- Roller compactors have become commonplace in the production of solid dosage pharmaceuticals. Low API content formulations can be problematic if the appropriate steps are [...]

Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University

UPPSALA, Sweden, January 13 -- Beactica AB, the Swedish fragment-based drug discovery company, today announced a new research collaboration agreement with GE Healthcare (Chalfont St. Giles, UK), the world leading provider of molecular interaction analysis tools, and Uppsala University (Sweden). The collaboration combines Beactica's unique approach to fragment-based drug discovery and GE Healthcare's Biacore(TM) technology [...]

Millipore Corporation Supports President-Elect Obama’s Plans to Review Stem Cell Research Policy

BILLERICA, Mass.--Millipore Corporation (NYSE:MIL - News), a leading provider of technologies, tools and services for the global life science industry, today announced it would support President-elect Barack Obama’s plans to review and possibly reverse an executive order that currently restricts federal funding for embryonic stem cell research. The comments were made by Millipore Chairman, President [...]

Celprogen Introduces Non-Viral Method to Reprogram Adult Somatic Cells (De-differentiation) to Their Embryonic Pluripotent Cells (iPCs)

SAN PEDRO, Calif.--Celprogen Inc. has announced that they have successfully De-DIFFERENTIATED Human Somatic Cells (primary skin fibroblast, keratinocytes, cardiac, liver and neuronal cells) to their embryonic like pluripotent cells (iPCs). This De-differentiation process was achieved with non-viral induction utilizing Celprogen’s De-differentiation media and matrix system for reprogramming adult somatic cells to iPCs in tissue culture. [...]

Varian, Inc. Announces Online Experience

PALO ALTO, Calif., Jan. 12 -- Varian, Inc. (NasdaqGS: VARI - News) has announced that it will host a unique online event involving the breadth and depth of its solutions for analytical and research applications as an alternative to participating as a booth exhibitor at Pittcon®2009. Varian recognizes the growing trend toward gathering information online. [...]

Access IBO on Knowledge Center